FDA Updates Black Box Warning for Benzodiazepines

The FDA announced that they are updating the “black box warning” for benzodiazepines. FDA will require Medication Guides and prescribing information for benzodiazepines to warn about the risks of physical dependence, withdrawal reactions, misuse, abuse, and addiction.

Read More »

Postpartum Depression: Brexanolone and Other Treatments

Postpartum Depression (PPD) affects between 10-15% of new mothers. PPD causes mothers to suffer from a long-lasting depression that, if severe, can put both the mother and the child in danger. Though PPD is common, available antidepressants are not guaranteed to help. A new treatment, brexanolone, offers hope for some mothers but also has severe side effects.

Read More »